HOME

TheInfoList



OR:

Surgicel is a
hemostatic agent An antihemorrhagic (antihæmorrhagic) agent is a substance that promotes hemostasis (stops bleeding). It may also be known as a hemostatic (also spelled haemostatic) agent. Antihemorrhagic agents used in medicine have various mechanisms of action: ...
(blood-
clot A thrombus (plural thrombi), colloquially called a blood clot, is the final product of the blood coagulation step in hemostasis. There are two components to a thrombus: aggregated platelets and red blood cells that form a plug, and a mesh of c ...
-inducing material) made of an oxidized
cellulose Cellulose is an organic compound with the formula , a polysaccharide consisting of a linear chain of several hundred to many thousands of β(1→4) linked D-glucose units. Cellulose is an important structural component of the primary cell wall ...
polymer (the unit is polyanhydroglucuronic acid), manufactured by the
Ethicon Ethicon, Inc. is a subsidiary of Johnson & Johnson. It was incorporated as a separate company under the Johnson & Johnson umbrella in 1949 to expand and diversify the Johnson & Johnson product line. Ethicon has manufactured surgical sutures and ...
subsidiary of Johnson And Johnson. It was introduced into clinical practice in 1947. It is used to control post-surgical bleeding. It is also used by some boxing
cutmen A cutman is a person responsible for preventing and treating physical damage to a fighter during the breaks between rounds of a full contact match such as a boxing, kickboxing or a mixed martial arts bout. Cutmen typically handle swelling, nose ...
to control bleeding. Surgicel is used extensively in oral and maxillofacial surgery to control intrabony arterial bleeds from the inferior alveolar artery. It is frequently used to stop bleeding following newborn circumcision if pressure alone is inadequate. When placed in the mandibular canal with the inferior alveolar nerve exposed there have been reports of neurotoxic effects. Common sizes include:


References


Surgicel at Johnson and Johnson

Surgicel in the management of epistaxis 1947
Antihemorrhagics {{surgery-stub